×
Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Age Related Macular Degeneration Market

ID: MRFR/Pharma/4281-CR
200 Pages
Rahul Gotadki
July 2025

Marché de la dégénérescence maculaire liée à l'âge : informations par type (dégénérescence maculaire humide liée à l'âge (DMLA humide) et dégénérescence maculaire liée à l'âge sec (DMLA sèche)) stade (dégénérescence maculaire liée à l'âge au stade intermédiaire, dégénérescence maculaire liée à l'âge à un stade précoce et dégénérescence maculaire liée à l'âge à un stade avancé) Groupe d'âge (plus de 75 ans, plus de 60 ans et plus de 40 ans) par traitement (traitement et diagnostic) Voie d'administration (voie d'administration intravitréenne et voie d'administration intraveineuse) Utilisateur final (hôpitaux et cliniques, centres de diagnostic et instituts de recherche universitaires) et région - Prévisions jusqu'en 2030

Partager
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Age Related Macular Degeneration Market Infographic
Purchase Options

Age Related Macular Degeneration Market Résumé

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Les principales entreprises du marché Age Related Macular Degeneration Market incluent

Portée du rapport

Faits saillants du marché

Auteur
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Laisser un commentaire

FAQs

What is the projected market valuation for Age-Related Macular Degeneration by 2035?

The projected market valuation for Age-Related Macular Degeneration is expected to reach 20.59 USD Billion by 2035.

What was the market valuation for Age-Related Macular Degeneration in 2024?

The overall market valuation for Age-Related Macular Degeneration was 8.45 USD Billion in 2024.

What is the expected CAGR for the Age-Related Macular Degeneration market from 2025 to 2035?

The expected CAGR for the Age-Related Macular Degeneration market during the forecast period 2025 - 2035 is 8.43%.

Which treatment method is projected to have the highest market value by 2035?

Anti-VEGF Therapy is projected to have the highest market value, expected to grow from 3.5 USD Billion to 8.5 USD Billion.

What are the key players in the Age-Related Macular Degeneration market?

Key players in the market include Regeneron Pharmaceuticals, Novartis, Roche, Bayer, Pfizer, Alcon, Horizon Therapeutics, Apellis Pharmaceuticals, and Santen Pharmaceutical.

How does the market for Dry Age-Related Macular Degeneration compare to Wet Age-Related Macular Degeneration?

The market for Dry Age-Related Macular Degeneration is expected to grow from 3.38 USD Billion to 8.0 USD Billion, while Wet Age-Related Macular Degeneration is projected to increase from 4.23 USD Billion to 9.8 USD Billion.

What distribution channel is anticipated to show significant growth by 2035?

Online Pharmacies are anticipated to show significant growth, with a projected increase from 2.12 USD Billion to 5.3 USD Billion.

Which patient demographic is expected to dominate the Age-Related Macular Degeneration market?

Elderly Patients are expected to dominate the market, with a projected growth from 3.5 USD Billion to 8.5 USD Billion.

What is the expected market value for Nutritional Supplements by 2035?

The expected market value for Nutritional Supplements is projected to rise from 2.45 USD Billion to 6.09 USD Billion by 2035.

How does the market for Optical Clinics compare to Retail Pharmacies in terms of growth?

The market for Optical Clinics is expected to grow from 1.69 USD Billion to 4.05 USD Billion, whereas Retail Pharmacies are projected to increase from 2.12 USD Billion to 5.12 USD Billion.

Research Approach

Research Methodology on Age-Related Macular Degeneration Market

1. Introduction

Research methodology is an important part of any research project. To create a valid and reliable research framework, the researcher must have a proper and detailed plan and methodology. This section explains the research methodology adopted for the study of the global Age-Related Macular Degeneration (AMD) market. The researchers have adopted a qualitative and quantitative approach to analyze the primary data gathered from the respondents.

2. Research Design

The research design adopted for this study is descriptive in nature. The researchers conducts detailed research to gain information about the global Age-Related Macular Degeneration (AMD) market. The research design used was exploratory to gain insights into the global Age-Related Macular Degeneration (AMD) market of different countries. The research design is considered suitable for this study as the researcher had complete control over the data collection process.

3. Research Approach

The researcher has adopted both primary and secondary approaches for the study of the global Age-Related Macular Degeneration (AMD) market. This helps the researcher gain a better understanding of the subject and ensures that the collected data is valid, reliable and accurate.

4. Sampling Technique

The researcher uses a simple random sampling technique to select the sample size of the study. The sample size is calculated based on the population size and the survey is conducted using the online method.

5. Data Collection & Analysis

Data is collected from both primary and secondary sources. Primary data is collected by conducting a survey where questionnaires are designed and distributed to the respondents. Secondary data is sourced from published journals, periodicals and other internet sources. Both qualitative and quantitative data are analyzed by the researcher.

Qualitative data is analyzed using thematic coding and coding is done based on the questionnaire responses. Quantitative data is analyzed statistically using appropriate software and descriptive statistics such as mean, median and standard deviation are computed.

6. Conclusion

This research report provides a detailed description of the research methodology adopted for the study of the global Age-Related Macular Degeneration (AMD) market. The research professionals used both qualitative and quantitative approaches to analyze the primary and secondary data. The research design and sample size selection are also discussed.

Télécharger l'échantillon gratuit

Veuillez remplir le formulaire ci-dessous pour recevoir un échantillon gratuit de ce rapport

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization
Direct Access to Analyst
Deliverable Format
Platform Access
Discount on Next Purchase 10% 15% 15%
Printable Versions